First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

The Talk

® The TALK features a group of subject matter experts discussing key datasets and exciting updates from recent oncology conferences in various cancer types. These video programs are designed to highlight important areas of research and hot topics in the field of breast cancer, lung cancer, and multiple myeloma, among specialties. 

Lower-Risk MDS: A Review of Data from the ASH 2022 Annual Meeting

Moffitt Cancer Center

Cancer Centers

Partner

Yale Cancer Center

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

The University of Texas MD Anderson Cancer Center

Hematologic oncology experts give an overview of first- and second-line treatment options for lower-risk myelodysplastic syndromes.

First- and Second-Line Treatment Options in Lower-Risk MDS

Luspatercept in Lower-Risk MDS

Emerging Therapies for Lower-Risk MDS